Baillie Gifford & Co’s Vir Biotechnology VIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,383,029
| Closed | -$17.8M | – | 283 |
|
|
2024
Q3 | $17.8M | Sell |
2,383,029
-1,538,213
| -39% | -$11.5M | 0.01% | 186 |
|
|
2024
Q2 | $34.9M | Sell |
3,921,242
-25,823
| -0.7% | -$230K | 0.03% | 156 |
|
|
2024
Q1 | $40M | Sell |
3,947,065
-18,484
| -0.5% | -$187K | 0.03% | 156 |
|
|
2023
Q4 | $39.9M | Sell |
3,965,549
-6,022
| -0.2% | -$60.6K | 0.03% | 163 |
|
|
2023
Q3 | $37.2M | Sell |
3,971,571
-11,874
| -0.3% | -$111K | 0.03% | 159 |
|
|
2023
Q2 | $97.7M | Sell |
3,983,445
-2,581
| -0.1% | -$63.3K | 0.08% | 124 |
|
|
2023
Q1 | $92.8M | Buy |
3,986,026
+1,425
| +0% | +$33.2K | 0.08% | 123 |
|
|
2022
Q4 | $101M | Buy |
3,984,601
+5,944
| +0.1% | +$150K | 0.11% | 111 |
|
|
2022
Q3 | $76.7M | Buy |
3,978,657
+47,805
| +1% | +$922K | 0.08% | 128 |
|
|
2022
Q2 | $100M | Sell |
3,930,852
-16,308
| -0.4% | -$415K | 0.1% | 121 |
|
|
2022
Q1 | $102M | Buy |
3,947,160
+31,659
| +0.8% | +$814K | 0.07% | 138 |
|
|
2021
Q4 | $164M | Buy |
3,915,501
+15,809
| +0.4% | +$662K | 0.09% | 118 |
|
|
2021
Q3 | $170M | Buy |
3,899,692
+50,183
| +1% | +$2.18M | 0.09% | 122 |
|
|
2021
Q2 | $182M | Buy |
3,849,509
+32,361
| +0.8% | +$1.53M | 0.09% | 128 |
|
|
2021
Q1 | $196M | Buy |
3,817,148
+72,200
| +2% | +$3.7M | 0.11% | 117 |
|
|
2020
Q4 | $100M | Buy |
3,744,948
+29,060
| +0.8% | +$778K | 0.06% | 131 |
|
|
2020
Q3 | $128M | Buy |
3,715,888
+252,686
| +7% | +$8.67M | 0.09% | 112 |
|
|
2020
Q2 | $142M | Buy |
3,463,202
+3,333,333
| +2,567% | +$137M | 0.11% | 103 |
|
|
2020
Q1 | $4.45M | Sell |
129,869
-370,131
| -74% | -$12.7M | ﹤0.01% | 184 |
|
|
2019
Q4 | $6.29M | Buy |
+500,000
| New | +$6.29M | 0.01% | 183 |
|